Geraldine Pannu - 27 Jun 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Geraldine Pannu by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
27 Jun 2023
Net transactions value
$0
Form type
4
Filing time
24 Jul 2023, 18:26:44 UTC
Previous filing
20 Jan 2023
Next filing
10 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +23,636 +80% 53,113 27 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Options Exercise $0 -23,636 -100% $0.000000* 0 27 Jun 2023 Common Stock 23,636 $0.000000 Direct F1
transaction PCSA Restricted Stock Award $0 +101,365 $0.000000 101,365 27 Jun 2023 Common Stock 101,365 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 The Restricted Stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.